• Health Care Reform

    Our experts are helping states navigate policy for
    successful implementation.

    Learn more arrow
    image discription

  • Mass. Leads Nation in Generic Use

    We can develop a formulary strategy for your state.

    Find out how arrow

    image discription

  • Health Insurance Exchange

    We are an early innovator in the development of cost-effective
    and sustainable health insurance exchanges.

    Learn more arrow
    image discription

  • Third-Party Liability

    We can save states billions of dollars in Medicaid cost
    avoidance and recovery.

    Find out how arrow

    image discription

  • Medical Home Model

    The patient-centered medical home is a key
    aspect of federal health care reform.

    Learn how we are piloting this in Mass. arrow

    image discription

News

Jay Himmelstein, M.D., M.P.H.
May 08, 2012
Princeton Conference to feature Commonwealth Medicine HIX expert

Jay Himmelstein to moderate a panel session on health insurance exchanges — “How Are States Progressing in Setting Up State-Based Exchanges?” — at the Princeton Conference, a national forum on health policy.

Who We are

Commonwealth Medicine is dedicated to improving health care for people in need, while also controlling costs and maximizing revenue for our clients.

Public- and private-sector organizations save millions of dollars annually by working with us. Our evidence-based recommendations and innovative solutions produce tangible results:

  • Better health outcomes
  • Lower health care costs
  • More access to health care

Our ability to apply objective academic research and public service knowledge makes a difference — both for our clients and the individuals they serve.

Where We’ll be Next...

Medicaid Enterprise Systems Conference

August 19-23, 2012 — Boston, Massachusetts

The annual Medicaid Enterprise Systems Conference (formerly known as the MMIS Conference) brings together thought leaders from the public and private sectors to share ideas and information related to Medicaid systems and initiatives

We will be exhibiting at this event.

Featured Publication

December 15, 2011
Pipeline Trends — December 2011 Pipeline Trends — December 2011

Pipeline Trends features concise, impartial data on drugs in development and their potential place in therapy. The most recent issue includes updates on alemtuzumab, AMR101, carfilzomib, insulin degludec, and other new drugs. 

The information in Pipeline Trends, a biannual publication, helps subscribers plan for future initiatives.

View: Pipeline Trends — December 2011